Related Experiment Video

Updated: Aug 1, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

[The hemostatic system in the acute coronary syndromes: physiopathological and therapeutic implications]

J A Páramo Fernández1, J Orbe Lopategui

  • 1Servicio de Hematología, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona. japaramo@anav.es

Revista Clinica Espanola
|April 24, 2004
PubMed

Insights

Acute coronary syndromes (ACS) involve plaque disruption and thrombus formation. Combining antithrombotic therapies significantly reduces ischemic events and prevents recurrences in ACS patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pathophysiology

Context:

  • Acute coronary syndromes (ACS), including unstable angina and myocardial infarction, stem from vulnerable atherosclerotic plaque rupture.
  • Atherothrombosis pathogenesis involves platelet activation and clotting cascade initiation at sites of endothelial injury.
  • Tissue factor plays a critical role in initiating thrombin generation and fibrin formation, stabilizing platelet-rich thrombi.

Purpose:

  • To elucidate the pathophysiological mechanisms underlying acute coronary syndromes.
  • To highlight the role of platelet aggregation and the coagulation cascade in atherothrombosis.
  • To underscore the therapeutic benefits of combined antithrombotic strategies in managing ACS.

Summary:

  • ACS pathogenesis is driven by the interaction between disrupted atherosclerotic plaques and subsequent thrombus formation.
  • Platelet adhesion, aggregation, and coagulation activation are key events following endothelial injury.
  • Tissue factor initiates the coagulation cascade, leading to thrombin generation and fibrin clot formation to stabilize the thrombus.

Impact:

  • Combined antithrombotic therapies, including fibrinolytics, antiplatelets, and anticoagulants, are crucial for managing ACS.
  • These strategies significantly reduce ischemic events and prevent recurrent episodes in patients with ACS.
  • Understanding atherothrombosis mechanisms informs the development of more effective ACS treatments.

More Related Videos

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...